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Dermal Absorption of a Dilute Aqueous Solution of Malathion
John E. Scharf, MD
ABSTRACT

Malathion is a commonly used organophosphate pesticide on field crops, fruits, nut trees,
vegetables, livestock, agricultural premises, and land. The approved uses also include
mosquito and medfly control. These uses can result in human skin contact. The purpose
of this study is to evaluate the human skin absorption of malathion for the purpose of
assessing the risks associated with aqueous solution exposures following applications.
Aerial applications can result in solubilized malathion in swimming pools and other
waters that may be contacted. Human volunteers were selected and exposed to aqueous
solutions of malathion at various concentrations. Participants submerged their arms and
hands in twenty liters of dilute malathion solution in either a stagnant or stirred
environment. The “disappearance method” was applied by measuring malathion
concentrations in the water before and after human subject exposure to the water for
various periods of time. Malathion was measured using Gas Chromatography. No
measurable skin absorption was detected in 42% of the participants. Measurable skin
absorption among the remaining 58% of participants resulted in doses that were more
than an order of magnitude less than the minimal dose necessary to cause a measurable
change in red blood cell acetylcholinesterase (RBC-AChE). Extrapolation of these results
to a mathematical model for recreational swimmers and bathers exposed to contaminated
swimming pools and surface waters typically detected after bait application again are an
order of magnitude below the doses needed to cause a detectable change in RBC-AChE.
These data indicate that exposure to aqueous malathion following usual aerial bait
applications is not appreciably absorbed, and therefore, it is not a public health hazard.
vi

Chapter One
Organophosphate Pesticides
Introduction. The use of organophosphate compounds as insecticides began in the 1930s
and has increased markedly since many organochlorine insecticides were banned in the
1970s. In contrast to organochlorine insecticides, organophosphate insecticides degrade
rapidly in the environment and do not accumulate or concentrate in the food chain. Thus,
organophosphates have less potential for chronic health effects or environmental
contamination than do organochlorines and pose less risk to consumers of food products.
However, organophosphate compounds have a greater potential for acute toxicity in
humans than do chlorinated compounds. Even among the organophosphate pesticides,
however, a wide spectrum of potency exists. As insects develop greater resistance, the
trend is to use more potent, and consequently, more lipid-soluble and longer-lasting
insecticides.
Malathion has a generally low mammalian toxicity in spite of its strong insecticidal
properties. Malathion itself has little or no cholinesterase activity. Like many other
organophosphates, malathion is activated by mono-oxygenase attack to produce the
potent anticholinesterase malaoxon. Malathion and malaoxon are rapidly detoxified in
mammals by carboxylesterase attack (but not insects) to produce their respective
monacids. If the carboxylesterase detoxification pathway is inhibited, mammals may be
made almost as sensitive as insects to malathion (Caldwell, 1983).
Malathion is metabolized in human liver by one of two pathways: (1) hydrolysis to nontoxic metabolites; or (2) oxidation to the active metabolite, malaoxon. Malaoxon has 68x
the inhibition of plasma cholinesterase activity as malathion. Furthermore, malaoxon is

1

generally acknowledged to be the actual inhibitor of plasma cholinesterase and to be the
primary compound responsible for the full spectrum of cholinergic symptoms observed in
poisoned subjects. Normally, the balance of metabolic reactions in the gut is heavily in
favor of oxidation to malaoxon in insects, but favors hydrolysis to non-toxic metabolites
in humans; thus the selective toxicity of malathion on insects vs. humans.
Physical Properties. In organophosphate molecules, R1 and R2 are usually alkyl groups
(typically ethyl or methyl). X is commonly an alkyl group that is replaced by a hydrogen
atom during irreversible inhibition, or “aging”, of the organophosphate-enzyme complex.

O (or S)
||
R1O---P---OR2
|
O---X
Figure 1: Organophosphate.

2

S
||
CH3O---P---OCH3
|
S---CHCOOC2H5
|
CH2COOC2H5
Figure 2: Malathion.
•

Appearance: Clear, amber liquid with penetrating garlic odor.

•

Chemical Name: diethyl (dimethoxy thiophosphorylthio) succinate

•

CAS Number: 121-75-5

•

Molecular Weight: 330.36

•

Water Solubility: 130 mg/L

•

Solubility in Other Solvents: very soluble

•

Melting Point: 2.85 C

•

Vapor Pressure: 5.5 x 10-6 mmHg at 20°C

•

Log Kow Partition Coefficient: 2.75

•

Specific Gravity: 1.23

3

O
||
CH3O---P---OCH3
|
S---CHCOOC2H5
|
CH2COOC2H5
Figure 3: Malaoxon.
•

Appearance: Colorless, oily liquid.

•

Chemical Name: diethyl ((dimethoxy phosphinyl) thio) butanedioate

•

CAS Number: 1634-78-2

•

Molecular Weight: 314.36

•

Water Solubility: 209 mg/L

•

Soluble in ethanol, methanol and acetone.

•

Melting Point: < 20 C

•

Vapor Pressure: 9.8 x 10-6 mmHg

•

Log Kow Partition Coefficient: 2.02

•

Specific Gravity: 1.23

4

O
||
CH3S---P---OCH3
|
S---CHCOOC2H5
|
CH2COOC2H5
Figure 4: Isomalathion.

O
||
CH3O---P---OCH3
|
SCH3
Figure 5: O,O,S-trimethyl phosphorothioate.

CHCOOC2H5
||
CH2COOC2H5
Figure 6: Diethyl Fumarate.

5

S
||
CH3CH2O---P---OCH2CH3
|
O
|
Benzene – NO2

Figure 7: Parathion.

•

Appearance: Deep brown to yellow liquid with a faint odor of garlic.

•

Chemical Name: O,O-diethyl O-4-nitrophenyl phosphorothioate

•

CAS Number: 56-38-2

•

Molecular Weight: 291.3

•

Water Solubility: 24 mg/l

•

Soluble in alcohols, oils, ethers.

•

Melting Point: 6 C

•

Vapor Pressure: 1.9 x 10-5 mm Hg

•

Log Kow Partition Coefficient: 3.83

6

Figure 8: Chlorpyrifos.

•

Appearance: Amber to white crystalline solid with a mild sulfur odor.

•

Chemical Name: O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate

•

CAS Number: 2921-88-2

•

Molecular Weight: 350.62

•

Water Solubility: 2 mg/L

•

Soluble in benzene, acetone, chloroform, ethers.

•

Melting Point: 44 C

•

Vapor Pressure: 2.5 mPa

•

Log Kow Partition Coefficient: 4.70

7

O
||
CH3S---P---OCH3
|
NH2

Figure 9: Methamidophos.

•

Appearance: Crystalline solid, with off-white color and pungent odor.

•

Chemical Name: O,S-dimethyl phosphora-midothiolate

•

CAS Number: 10265-92-6

•

Molecular Weight: 141.12

•

Water Solubility: 90 g/L

•

Solubility in solvents unavailable.

•

Melting Point: 44 C

•

Vapor Pressure: 3 x 10-4 mmHg

•

Log Kow Partition Coefficient: NA

(Extoxnet, 2003).
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Table 1: Physical Properties and Partition Coefficients (K) of Malathion vs. Malaoxon.
System

Malathion

Malaoxon

Lipid Solubility

More soluble

Less soluble

2.75

Log Kow

2.02

Log K Chloroform-water

64

5.8

Log K Hexane-water

19

0.42

Log K Petroleum ether-ethanol

11

1.8

Log K CCl4-water

39

2.9

Cuticle Penetration

Better

Worse

Alkaline Hydrolysis Stability

More stable

Less stable

AntiAChE activity

Poor

Good

I50 Inhibit AChE Conc. (M)

1 x 10-4

4 x 10-7

Oxidation of malathion to malaoxon greatly increases partitioning into polar solvents, but
less likely to penetrate skin (O’Brien, 1957) (Miller, 1998).
Exposure Pathways.

The site of introduction of a xenobiotic into the organism

qualitatively governs the initial exposure. An orally administered compound has to
traverse the intestines, the liver, and the lung before it reaches the systemic circulation.
Due to this ‘first-pass effect’, the amount that reaches the systemic circulation is much
less than the amount administered. In contrast, this ‘first-pass effect’ is bypassed through
dermal absorption. The entire amount systemically absorbed through the skin is passed
through the lungs by the venous blood before it is retuned to the heart and distributed by
arterial blood to the vital organs (Caldwell, 1983).
Most exposures to organophosphates occur from skin absorption. Skin absorption can
occur when dermal contact is made during handling and application, and when contact is
made with chemical residues on plants, fruits, and foliage; in soil; and in dust particles
after spraying. Organophosphate insecticides such as malathion are applied in the sulfurcontaining (-thion) form, but readily undergo desulfuration to form a more toxic oxygen-
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containing (-oxon) form. In the field, this conversion occurs slowly under the influence of
oxygen and light, producing residues with altered physical properties and potentially
more toxic as well.
Biologic Fate. Skin absorption of malathion is incomplete because much of the applied
dose is lost from the skin surface by washing, evaporation and gradual exfoliation of the
outer layers of the stratum corneum. The amount absorbed into the body depends on a
relationship between the speed with which it penetrates the skin and the speed with which
it is lost from the skin surface. Importantly, systemic absorption after skin application can
be delayed, and the resultant absorption rate across skin is much slower than across
mucous membranes. Typically, experimental subjects differ by a factor of five in the
amount of malathion percutaneous penetration, with standard deviations up to one half
the mean value. Thus, assuming a normal distribution, one person in ten will absorb twice
the mean value, while one in twenty will absorb three times that amount.
Dary exposed human forearms to 1% malathion aqueous solution, placing an occlusive
patch over the exposure site after 4 hours of observation. This occlusive patch was
removed at 24 hours, analysis of which revealed 65% of the applied dose. This amount in
the occlusive patch may represent evaporative and mechanical loss potential. Preliminary
mass balance over the initial 24-48 hour post-exposure period was as follows:
•

70% of initial applied dose removed by washing skin surface-epidermis;

•

40% of the remaining dose (12% of initial dose) slowly lost through evaporation;

•

60% of the remaining dose (18% of initial dose) retained in dermis;

•

90% of the dermal to systemic dose is eliminated in urine;

•

15% of the initial applied dose is systemically absorbed and eliminated in urine.

The slow rate of dermal absorption and efficient rate of elimination by liver
carboxylesterases and kidneys reduce the risk of acute toxicity; however, repeated
exposures could burden these same organs of metabolism and elimination (Dary, 1994).
Although the skin is often considered as merely acting as a passive barrier to the entrance
of chemicals, it is clearly capable of metabolizing endogenous substances as well as
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drugs and other exogenous chemicals. Despite the low activity of metabolic enzymes in
skin, it must be appreciated that skin is the largest organ in the body, comprising 5% of
total body weight. Thus, the skin can contribute significantly to total metabolism of
chemicals. For example, skin is well known to contain cytochrome P-450, NADPHcytochrome c-reductase and glutathione S-transferase. Cutaneous enzymes with monooxygenase activities such as these can be induced by a variety of xenobiotics.
Immunohistochemical investigations have documented the epidermis, sebaceous glands,
and hair follicles as the sites of xenobiotic activation and detoxification within the skin
(Caldwell, 1983).
Parathion, a closely related organophosphate to malathion, has demonstrated unusual
percutaneous absorption kinetics and systemic toxicity patterns. For example, in an
isolated perfused porcine skin flap model of parathion, almost 70% of the parent
compound parathion penetrated the skin into the perfusate as paraoxon. Thus,
biotransformation of topically dosed organophosphates by skin-based cytochrome p450
enzymes to the more toxic –oxon form may play a crucial role in risk assessment (Carver
1988) (Kao, 1990).
In the mammal, vigorous hepatic hydrolytic degradation of organophosphates at the
carboxylic ester link typically outstrips the process of accumulation caused by oxidation.
Hepatic conversion is brought about chiefly by microsomal esterases. This hydrolyzing
system of the liver is more active against malathion than malaoxon; ultimately, however,
both –thion and –oxon forms are metabolized to non-toxic alkyl phosphate mono-acids
and excreted rapidly. In the rat model, after oral malathion ingestion, twelve hour urine
samples contained 1% of the dose as malaoxon mono-acid and 67% as malathion acids
(Kizer, 1991). On the other hand, in the cockroach insect, both fat body and midgut
metabolic systems oxidize malathion to malaoxon, but only the fat body hydrolyzes
malaoxon to the non-toxic alkyl phosphate. In the insect, then, oxidation is much more
rapid than hydrolysis, thus malaoxon may accumulate steadily to a lethal level (O’Brien,
1957).
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Physiologic Effects.

Organophosphates combine with and inhibit cholinesterase

enzymes, of which acetylcholinesterase (AChE) in nerve tissue is the most important.
After conversion of malathion to its oxygen analog, malaoxon, the active site of AChE is
phosphorylated (and inhibited) by dimethyl or methyl phosphate. Inactivation of AChE
results in accumulation of acetylcholine at the neuroreceptor transmission site, resulting
in massive overstimulation of the cholinergic system as follows:
•

Accumulation of acetylcholine in the muscarinic autonomic receptors cause
miosis, tearing, salivation, perspiration, nausea, vomiting and diarrhea.

•

Accumulation of acetylcholine in the nicotinic neuromuscular receptors cause
fasciculations, cramps and weakness.

•

Rising accumulation of acetylcholine in the central nervous system cause sensory
and behavioral disturbances, incoordination, depressed cognition, and respiratory
failure.

Biologic Indicators. Detection of intact organophosphate compounds in blood is usually
not possible. In general, organophosphates do not remain unhydrolyzed in the blood more
than a few minutes. Alkyl phosphate metabolites can often be detected in the urine up to
48 hours after exposure. The appearance of these urinary metabolites can demonstrate
pesticide absorption at lower dosages than those required to depress cholinesterase
activity. Occupational malathion exposures have resulted in dimethyl-dithiophosphate
(DMDTP) serum concentrations ranging to 3.5 mg/L (Shafnik and Enos, 1969). Up to
23% of a single oral dose of malathion is excreted in the 16 hour urine as etherextractable phosphates, where biological activity was estimated via colorimetry (Mattson
and Sedlak, 1960).
Red Blood Cell (RBC) cholinesterase, the same enzyme found in the nervous system, is a
useful surrogate indicator for AChE activity at neuroreceptor sites. RBC cholinesterase
activity is generally only restored as new red blood cells are formed at 1% per day.
However, it is notoriously difficult to interpret cholinesterase inhibition without baseline
values because normal values vary widely. The laboratory normal range is not useful
because upper and lower limits typically differ by a factor of four. RBC cholinesterase
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inhibition from 25-50% of the individual’s baseline is generally regarded as evidence of
toxicity, or the Lowest Observable Adverse Effect Level (LOAEL).
In the best available No Observable Adverse Effect Level (NOAEL) study, volunteers
ingested 16 mg of malathion daily for 47 days without effect on RBC Cholinesterase.
Doses of 24 mg, however, when administered for 56 days caused 25% depression of RBC
cholinesterase, with maximal effects occurring three weeks after administration. No
clinical signs or symptoms were noted in spite of the RBC cholinesterase depression
(Moeller and Rider, 1962).
Demyelination and Phospholipid Peroxidation. In humans and other vertebrates, reaction
of organophosphates with neuropathy target esterase (NTE) may initiate events which
culminate

in

axonal

degeneration.

Organophosphates

inhibit

biosynthesis

of

phospholipids which in turn may cause peroxidation of the myelin sheath. Thus, toxic
organophosphate exposure may result in demyelination-induced neurotoxicity. For
example, toxic malathion exposure in rats has induced spinal cord phospholipid
peroxidation (Haque, 1987).
Chlorpyrifos is heavily used for agricultural and domestic purposes due to its persistence
and relative safety compared to other organophosphate insecticides. Unlike parathion,
chlorpyrifos evokes delayed neuropathies only with very high exposures. Animal studies
confirm that chlorpyrifos has an order of magnitude higher systemic toxicity in neonates.
Perhaps more alarmingly, recent studies in rats have shown that chlorpyrifos, in doses
below the threshold for symptoms of systemic toxicity, nevertheless can compromise the
basic cellular processes of brain development.
In the neonate, programming of brain cell reactivity and synaptic connections are at their
peak and are thus most vulnerable. In the neonate, the adverse effects of cholinesterase
inhibition are exacerbated by poor synaptic adaptability to cholinergic hyperstimulation.
In a neonatal rat animal model after chlorpyrifos exposure at doses that do not cause
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systemic toxicity, there was alteration in coordination skills and locomotor activity (Dam,
2000).
In a similar neonatal animal model, chlorpyrifos exposure during the period of brain cell
acquisition and axonogenesis resulted in neuronal loss and abnormalities of
synaptogenesis. The adverse effects on cholinergic neurotransmission are a particular
concern since cholinergic pathways are critically important for cognitive function. In fact,
neonatal exposure in rats produced lasting reductions in hippocampal cholinergic
presynaptic activity. Short-term behavioral studies in this animal model indicated
alternations in several activity measures, and additional effects on activity emerged well
after the end of cholorpyrifos administration (Levin, 2001).
These results (e.g. alterations in behavior and locomotion) stress the importance of
looking beyond the acute period of organophosphate exposure for adverse effects.
Indeed, developmental deficits may appear well after organophosphate exposure and
cholinesterase inhibition have disappeared.
Delayed Neuropathy. Shortly after organophosphate exposure, a weak reversible bond is
formed with AChE. With time, however, a more permanent AChE-phosphate bond forms
(“aging”) that inactivates the enzyme and requires an antidote to break. If an antidote
such as pralidoxime [2-PAM] is not given within 24-48 hours after exposure, the AChEphosphate bond becomes so strong that physiologic recovery depends on de-novo
synthesis of AChE. At the nerve junction, AChE is restored in an average of two weeks;
in the body as a whole, it may require up to three months to restore enzyme activity to
near normal levels (Pope and Rall, 1995).
Symmetric distal axonal degeneration is a systemic health effect caused by some
organophosphates that is not due to AChE inhibition. The degeneration is a dying back of
large diameter axons and their myelin sheaths in distal parts of the peripheral nerves and
in long spinal cord tracts. This degeneration is caused by inhibition of a neuronal,
nonspecific carboxylesterase known as neuropathic target esterase (NTE), essential for
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lipid metabolism in neurons. The resulting clinical syndrome, organophosphate-induced
distal neuropathy (OPIDN), typically begins one to two weeks after exposure, and
consists of flaccidity, paralysis and paresthesias of the lower extremities.
All organophosphates inhibit acetylcholinesterase (AChE), but only a subset of these
inhibit neuropathy target esterase (NTE), the enzyme definitively associated with
OPIDN. In essence, a sufficient amount of NTE must be irreversibly inhibited by the
organophosphate before the OPIDN syndrome may occur. In vitro (neuroblastoma cells)
and in vivo (hen, cat, and sheep) testing have established organophosphate-specific NTE /
AChE inhibition ratios, and correlated this ratio precisely with the ability to produce the
OPIDN syndrome. Previous work has shown that if AChE / NTE Inhibition Ratio >> 1,
the dose required for producing OPIDN >> LD50. Accordingly, malathion, parathion,
chlorpyrifos, dichlorvos and trichlorfon have not been linked to OPIDN.
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Table 2: Organophosphates, OPIDN, and AChE / NTE Inhibition Ratio.
Organophosphates linked to OPIDN:

AChE / NTE Inhibition Ratio:

•

DFP [diisopropyl fluorophosphonate]

5.3

•

TSP [cyclic tolyl saligenim phosphate]

1.5

•

PSP [cyclic phenyl saligenim phosphate]

0.12

•

Mipafox

1.1

•

DBVP

0.81

•

DOVP

0.56

•

EPN [ethyl nitrophenyl phenylphosphonate]

•

Leptophos

•

Merphos

•

Tri-ortho-cresyl phosphate [TOCP]

•

Tri-ortho-tolyl phosphate [TOTP]

•

Triaryl phosphate

•

Methamidophos

Organophosphates not linked to OPIDN:

AChE / NTE Inhibition Ratio:

•

Parathion

700,000

•

Malathion

76,000

•

Isomalathion (1R, 3R)

49000

•

Isomalathion (1R, 3S)

150000

•

Isomalathion (1RS, 3RS)

9100

•

Isomalathion (1S, 3R)

2500

•

Isomalathion (1S, 3S)

1500

•

Chlorpyrifos

•

Dichlorvos [DDVP]

42

•

Trichlorfon

68

200

(Rosenstock, 1991) (Jianmongkol, 1996) (Ehrich, 1997).
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Although there are no known case reports of OPIDN specifically linked to malathion,
malathion exposure has been listed at least as a contributory factor in a significant
OPIDN case series examination. In this series, exposed patients had moderate increases
in vibrotactile thresholds in the lower extremities. These results suggest that previously
reported OPIDN cases may represent only the worst disease in a spectrum of
polyneuropathy impairment, a sequelae of organophosphate exposure that may be much
more common than previously thought (McConnell and Rosenstock, 1994).
To evaluate the latent neurological effects of organophosphate poisoning, an
epidemiological study matched 100 pairs of individuals with previous acute
organophosphate poisoning and non-poisoned controls. Ten different organophosphates
were listed as the cause of primary poisoning, most being parathion, but of which six
were due to malathion. In the neurological examination component of the study, clear
abnormalities were demonstrated in the organophosphate exposed group in memory,
abstraction, mood, motor reflexes and simple motor skills. In the psychological
examination component, clear abnormalities were demonstrated in intellectual
functioning, academic skills, abstraction and flexibility in thinking. Minnesota
Multiphasic Personality Inventory analysis revealed greater distress and complaints of
disability for the poisoned subjects. Twice as many cases as controls had Halstead-Reitan
Battery summary scores in the range characteristic of individuals with cerebral damage or
dysfunction (Savage EP, 1988).
Delayed polyneuropathy (DP) is typically caused by organophosphate induced inhibition
of NTE, the enzyme essential for normal neuronal and axonal processes. DP is
characterized as a distal sensori-motor axonopathy, beginning about two weeks after
toxic exposure, with recovery beginning six to twelve months later. The best available
case report of malathion-induced delayed polyneuropathy (DP) occurred in 1990 as
follows:
A 65yo female was admitted to the hospital in cholinergic crises with muscarinic,
nicotinic and central effects after deliberate ingestion of 100 ml of malathion (235 mg/kg)
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dissolved in isoproponal. Artificial ventilation, atropine and pralidoxime were initiated
immediately. The patient was found to have complete and total depression of serum
cholinesterase. The patient regained consciousness and strength a few days later, and was
noted to have complete normalization of serum cholinesterase on day 12. Her
hospitalization was further complicated by pneumonia and acute respiratory distress
syndrome. At day 10, her muscle strength began to deteriorate again with loss of deep
tendon reflexes. Distal muscles were more involved than proximal ones. On day 35, a
gastrocnemius muscle biopsy showed evidence of denervation and reinervation. A sural
nerve biopsy showed degenerating axons, moderate loss of myelinated fibers and clusters
of small regenerating axons. Six weeks after admission, muscle strength began to recover
and was normalized after three months. This patient was found to have exposure to a
significant pesticide residue as the key DP causative factor: isopropyl-malathion (Argiles,
1990).
Organophosphate intoxication will cause cholinergic stimulation acutely, but delayed
neuropsychiatric sequelae may also result in a subacute paralytic syndrome known as the
intermediate syndrome. Intermediate syndrome is characterized by deterioration of
muscle strength and mental status about 48 hours after the acute presentation. Typically
weakness manifests itself within the neck and proximal muscles, which may include the
cranial nerves and the diaphragm. Motor recovery may take 5-20 days and most patients
will not develop polyneuropathy. Behavioral manifestations include depression,
psychosis, aggression, irritability, and memory and concentration problems. The best
available case report of malathion-induced intermediate syndrome occurred in 1998 as
follows:
A 44yo female was found in cholinergic crises with muscarinic, nicotinic and central
effects after deliberate ingestion of 125 ml of malathion (50% solution). Artificial
ventilation, atropine and pralidoxime were initiated immediately. Her hospitalization was
further complicated by bronchorrhea requiring glycopyrollate and pneumonia. She was
eventually transferred out of intensive care to the medical ward on day 13. On day 23, she
began displaying agitation, disorientation, hallucinations and somatic delusions. She
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became aggressive and inappropriate, voiding on the floor and throwing feces, and was
transferred to a psychiatric ward. Her delirium resolved over 48 hours with psychiatric
treatment, and she was discharged from the hospital on day 35 (Choi, 1998).
Racemic Isomalathion. Commercial malathion is supplied as a racemic (RS) mixture of
the R and S forms arising from an asymmetric carbon in its diethyl thiosuccinate group.
The corresponding steroisomers of malaoxon differ 8.6-fold in their inhibitory potencies
against rat brain AChE. Thermal or photochemical isomerization may occur during
storage of racemic malathion to yield racemic isomalathion, which is 1000-fold more
potent than the parent compound.
Shelf storage of malathion at 38C increases both its isomalathion content and its toxicity.
For example, unusually high levels of isomalathion were linked to 2800 poisonings
including 5 fatalities among 7500 Pakistani spraymen using malathion for malaria control
(Baker, 1978). Contamination of malathion by isomalathion acts synergistically to
increase toxicity by inhibiting the detoxification potential of liver carboxylesterase
enzymes.
Isomalathion contains two asymmetric centers, one at phosphorus, and the other at the
carbon in the diethyl thiosuccinate moiety, yielding four stereoisomers. Inhibitory
potencies of these isomers against AChE differ by as much as 29-fold. Individual
stereoisomers each form Michaelis complexes with this enzyme prior to the expulsion of
the primary leaving group and organophosphorylation of the active site serine.
Subsequently, the inhibited enzyme could undergo either reactivation (displacement of
the entire organophosphoryl group) or aging (scission of a ligand from the inhibitor,
leaving a negatively charged organophosphoryl group).
Aging to yield a negative charge in the active site leaves the enzyme intractable toward
reactivation. Diethyl thiosuccinate is the primary leaving group for R-isomalathion, while
thiomethyl is the primary leaving group for S-isomalathion. This unexpected
stereochemically determined switch in the inhibition mechanism potentially extends the
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range of toxicological consequences arising from exposures to the isomalathions. Aging
of both electric eel AChE and equine seurm butyrylcholinesterase (EBChE) by Smalathion via an SN2 reaction with P-S bond cleavage to yield an O-methyl phosphate
adduct has recently been reconfirmed (Doorn, 2001).
Apart from cholinergic toxicity elicited by AChE inhibition, some organophosphate
compounds inhibit and age >70% NTE, producing the OPIDN syndrome. Certain
structural requirements have been elucidated for organophosphate inhibitors of NTE. For
a given primary leaving group, longer-chain dialkyl ligands on phosphorus are preferred
over dimethyl or diethyl analogs, and small leaving groups are favored among longerchain dialkyl-substituted organophosphates. Considering these structure activity
relationships, malaoxon isomers and the isomalathions would be expected to be poor
inhibitors of NTE if diethyl thiosuccinate were the primary leaving group. However, if
thiomethyl were the primary leaving group, as found in the S-isomalathion configuration,
then inhibition of NTE would appear to be a reasonable possibility.
In view of unexplained reports of neuropathic sequelae associated with malathion
intoxication in humans, and the fact that isomalathions can arise as impurities in
malathion preparations, and the fact that isomalathions are potent inhibitors of esterases
other than NTE, the possibility exists that these compounds could be potentiators, rather
than initiators, of neuropathic processes (Healy, 1959) (Harell, 1978) (Rivett, 1987)
(Komori, 1991) (Jianmongkol, 1996).
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Chapter Two
Skin Absorption

Introduction. Interest in skin permeability arises mainly from the capacity of the skin to
limit the body’s accumulation or elimination of substances by percutaneous transport.
Although a complex process, dermal uptake of compounds occurs mainly through passive
diffusion, involving a selective mechanism in the lipid and protein structures of the
stratum corneum. This epidermal skin barrier is the major factor in this process and can
reduce overall rates of accumulation by several orders of magnitude. For example, watersoluble, low molecular weight, non-electrolytes can diffuse into the bloodstream 1000
times more rapidly if the epidermis is diseased, damaged, or removed. Even with the skin
intact, there are still 10,000 fold differences in the rates of penetration of different
substances.
Stratum Corneum. The principal barrier function of the epidermis resides almost entirely
in the stratum corneum, the thin coherent membrane of keratinized, epithelial cells that
comprise the “dead” surface layer of the epidermis. The phenomenon of percutaneous
absorption is essentially one of adsorption onto the stratum corneum (10 um thickness),
diffusion through it and through the viable epidermis (100 um thickness), and finally
through the papillary dermis (100-200 um thickness) and into the microcirculation.
The composite skin layer is pierced by two types of diffusion shunts: hair follicles and
sweat glands. Sebaceous glands are attached to follicular walls at distances of 500 um
below the surface, and for this reason their effectiveness as shunts is probably negligible.
Hair follicles (40-70/cm2) and sweat glands (200-250/cm2) do act as diffusion shunts,
but their role is more subtle than one might think. Although the fractional area covered by
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these appendages is only 0.1%, diffusion constants of low-molecular weight molecules
moving through the appendages are greater than through stratum corneum. Before steadystate diffusion is established, and particularly during the first few minutes after the
application of a substance, the follicles and ducts cannot always be ignored even when
the ultimate steady-state flux through these shunts is small.
The slow rate of malathion dermal absorption and its efficient rate of elimination reduces
the risk of acute toxicity for all exposures except when involving substantial portions of
unprotected skin. Water as a common vehicle may play an important role in increasing
the permeability of malathion in the stratum corneum. If penetrants are easily dissolved in
their oil vehicles applied to the skin, penetration is more difficult. For example, carbon
disulfide and analine are absorbed through the skin about 100 times faster from aqueous
solutions compared with oil solutions. The comparatively high rate of skin absorption of
compounds from their aqueous solutions seems to be a rule that could be related to the
hydration of stratum corneum (Scheuplein, 1965) (Baranowska-Dutkiewicz, 1982). If the
skin is hydrated, or the compound is in solution, diffusion and penetration will be
enhanced. On the other hand, stratum corneum may be subject to compaction and
dehydration when in contact with pure solvents. In addition, the necrotizing effects of
concentrated solvents in contact with skin act to limit absorption. Such data indicate that
skin absorption rates from dilute aqueous solutions may be seriously underestimated.
The entire skin and not just the stratum corneum can interact in important ways with
solvent mixtures. One might conceptualize percutaneous absorption as a process of
diffusion through the stratum corneum, followed by systemic uptake at the epidermaldermal junction. Furthermore, evaporation from the skin surface, reservoir formation in
the dermis, and percutaneous penetration are interrelated processes that are important in
determining the fate of topically applied compounds. Rapid penetration into the dermis
may occur with pesticides even after attempted soap and water decontamination
(Reifenrath, 1991).
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Intercellular spaces in the stratum corneum are normally filled and mechanically
coherent. The conversion of aqueous epidermal cells into dried, compact, keratincontaining stratum corneum cells is the crucial event in the continuously developing
epidermis that largely determines the low permeability of skin. The viable skin tissue
layers and the capillaries are relatively permeable, and the peripheral circulation
sufficiently rapid so that for the great majority of substances diffusion through the
stratum corneum itself is rate limiting. The usual diffusion laws of physics pertaining to
passive diffusion processes can therefore be applied to skin permeability phenomena and
greatly aid in its description.
The rate-limiting barrier within the stratum corneum is typically the hydrated intercellular
keratin. This keratin has an affinity for both water-soluble and lipid-soluble compounds.
Keratin’s bi-functional solubility arises from its inherently mosaic, filament-matrix ultrastructure which allows aqueous and lipid regions to exist separately. For this reason,
attempts to predict permeability constants from correlations with oil-water partition
coefficients (Kow) have proved only marginally successful. For larger molecules and
molecules with several polar groups, the relative importance of the stratum corneum
increases still further (Scheuplein, 1971).
Fick’s Law. Many investigators have reported on the toxicity and unexpectedly high
penetration rates of volatile organic compounds. Through relatively simple analysis of
absorption from specific compounds, it is possible to estimate potential absorption using
Fick’s Law. Dose may then be calculated using experimentally-derived skin absorption
rates and constants (Kp). Fick’s Law essentially describes the behavior of dilute aqueous
solutions, such that absorption of the solute will be directly proportional to concentration.
In more detail, Fick’s Law may be used to determine the permeation rate of solvents in an
aqueous solution, and is expressed by the formula:
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Js = Kp * ∆C
Where:
Js = permeation rate (flux) of the solute expressed as mcg/cm2;
Kp = permeability constant expressed as liters / cm2 / hr;
∆C = concentration difference of the solute across the specified tissue in mcg/L.
For example, using Fick’s Law, permeability constants for the following compounds in
weak aqueous solutions were experimentally derived:
Table 3: Reference Permeability Constants (Kp).
Compound

Aqueous Solution

Permeability Constant

Concentration: (mg/L)

Kp (L / cm2 / hr)

Ethylbenzene

112

.00100

Toluene

180

.00090

Styrene

66

.00060

Carbon Disulfide

1000

.00050

Trichloroethylene

100

.00020

Chloroform
Aniline

0.5

.00012

10000

.00004

(Dutkiewicz and Tyras, 1967, 1968).
Skin absorption rates are typically derived from experimental situations where the hands
and wrists are immersed in test solution. Rates obtained in this manner, however, will
underestimate actual absorption in cases of whole-body immersion during swimming.
The epidermis of the hand represents a relatively greater barrier to penetration than many
other parts of the body, especially hair-follicle-rich areas. For example, the scrotum has
an imperfect stratum corneum because of the enormous demands made on it in terms of
flexibility, and is well known to absorb almost all of several pesticides. In addition, the
face, forehead, scalp and neck absorb 2-6 times more than the forearm. Hands and feet
absorb about as much as the forearm, but absorption is slower. Larger areas of the body,
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such as the back, allow greater absorption than the forearm (Feldmann and Maibach,
1974).
Table 4: Malathion Anatomical Dermal Absorption Rates and Ratios in Humans.
Ratio

Rate: %Dose Recovered in Urine at 0-5 days

Palm

0.9

Forearm

1.0

6.8 ± 2.3%

Foot

1.0

6.8 ± 3.2%

Abdomen

1.4

9.4 ± 7.9%

Hand, Dorsum

1.8

12.5 ± 4.0%
5.8 ± 2.9%

Hand, Palm
Scalp

3.7

Jaw Angle

3.9

Forehead

3.4

Ear

4.0

Axilla

4.2

Scrotum

23.2 ± 9.1%
28.7 ± 13.7%

11.8

Malathion concentration at 4 mcg/cm2 in a non-occlusive acetone vehicle.
Subjects requested not to wash the site of application for 24 hours.
(Maibach, 1971).
Quick reference to a Lund and Browder Chart shows that forearm and hand surface area
compared to total body surface area is 11:100, or Fs = 0.11. Adjusting this figure for
Maibach’s relative absorption characteristics in different body surface areas yields an
adjusted factor of 11:142, or Fsadj = .0775.
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Table 5: Body Surface Area by Relative Absorption.
Anatomic

Surface

Relative

Multiplication

Location

Area

Absorption

Factor

Head

7%

3.7

25.9

Neck

2%

2.0 (est)

4

Ant Trunk

13%

1.4

8.9

Post Trunk

13%

1.4 (est)

8.9

Buttocks

5%

1.0 (est)

Genitalia

1%

Both Upper Arm

8%

1.0 (est)

8

Both Lower Arm

6%

1.0

6

Both Hands

5%

1.0

5

Both Thighs

19%

1.0 (est)

19

Both Lower Legs

14%

1.0 (est)

14

Both Feet
Total

11.8

7%

1.0

100%

`

5
11.8

7
142.1

(Brown, 1984).
Rate of Absorption. The entire skin, not just the stratum corneum or epidermis, can
interact in important ways with topically applied compounds. Evaporation from the skin
surface, reservoir formation in the dermis, and percutaneous penetration are interrelated
processes that are important in determining the fate of topically applied compounds.
Rapid penetration into the dermis may occur with organophosphates and may account for
percutaneous absorption even after one minute of decontamination with soap and water.
(Reifenrath, 1991).
Percutaneous penetration rates are determined by the physiochemical properties of a
compound such as molecular weight, solubility, charge distribution, partition coefficients,
and various other parameters. Correlations are consistent for compounds having closely
related chemical structures. However, meaningful results are often inconsistent where
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chemicals of diverse structure are compared. The rate of dermal uptake of malathion
compared to other insecticides was assessed in a shaven mouse skin model (upper
shoulder). As shown in Table 6, and compared to the 13 other insecticides investigated,
malathion exhibited the longest half-life and the least penetration.
Table 6: Pesticide Rates of Dermal Absorption in Mice.
Compound:

Half-life:

Penetration:

Excretory

GI

Carcass

1 hr

8 hr

8 hr

8 hr

8 hr

Carbaryl

13 min

72%

88%

73%

8%

6%

Chlordecone

41 min

54%

66%

4%

20%

25%

Parathion

66 min

32%

85%

50%

10%

17%

Dieldrin

72 min

34%

83%

4%

12%

62%

DDT

105 min

34%

71%

4%

15%

41%

Malathion

130 min

25%

67%

2%

33%

30% (urine)

Penetration is disappearance of radioactivity from 4 cm2 shaved skin, upper shoulder.
(Shah, 1981).
It is notable that malathion dermal penetration rates are quite variable in nature among
different mammalian species. In Yorkshire swine, after non-occlusive malathion
application to the ventral abdominal skin, corrected systemic absorption was only 5% at 6
days. Systemic absorption for malathion as a percentage of the original dermal dosage
was less than all other compounds tested (benzoic acid > progesterone > caffeine >
testosterone > parathion > malathion) in Yorkshire swine (Carver, 1989). In rats, after
non-occlusive malathion application to 10 cm2 shaven dorsal back for 8 hours,
autoradiograms demonstrated 28% of the dose concentrated at the application site, 29%
in the skin at large, and 23% contained in the urinary bladder (Saleh, 1997).
Complex mathematical models for the dermal absorption of a dilute malathion solution in
humans are available. A physiologically-based pharmacokinetic (PBPK) model has been
created that utilizes tissue volume compartments, air and blood flows, and chemicalspecific partition coefficients. PBPK incorporates seven body compartments (skin
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surface, skin perfused, fat, muscle, kidney-vessel rich group, intestine, and liver) and four
external compartments (air, urine, feces, and acid metabolites). Skin evaporation and
oxidative metabolism of malathion to malaoxon are incorporated into this model as well.
This adult PBPK model, which notably assumes Kp-malathion = 0.001 L/cm2/hr, predicts
during total immersion scenarios that 7-31% of the applied dose will be systemically
absorbed. Furthermore, 70% of that systemically absorbed dose is metabolized and
excreted within 24 hours (Kizer, 1991).
PBPK rate constants were chosen to approximate experimental data. The model’s skin
permeability constant (Kp = 1 x 10-5 /min to 5x10-4 /min, skin surface to viable epidermis)
was less than the skin evaporation constant (Kevap = 8 x 10-5 /min to 5 x 10-4 /min, skin
surface to air)). This important ratio, Kp/Kevap≤1, was based upon several classic studies.
Maibach demonstrated in three studies that 4%, 8%, and 7% of [C14]-malathion applied
to human forearm skin was excreted in 0-7 day urine samples. Peak excretion was 8
hours post-application. As shown in Table 4, up to 29% urinary recovery came from
more absorptive (but smaller surface area) parts of the body (Webster and Maibach,
1983) (Feldmann and Maibach, 1974) (Maibach, 1971). Increasing air flow over the
surface of excised pig skin undoubtedly increases evaporative loss for malathion.
Significant evaporative loss for malathion occurred from both the skin surface-epidermis
layer and the dermis layer. In fact, increased air flow decreased malathion dermal
residues but not parathion, DDT, nor DEET dermal residues. Penetration of the applied
malathion dose at 48 hours in the excised pig skin model decreased from 21% to 9% as
air flow was increased from 60 to 600 ml/min (Reifenrath, 1991).
Total Immersion.

Swimming pool and bathing immersion models show that skin

absorption represents a significant route of exposure. In fact, dermal absorption can
contribute from 29-91% of the total daily dose, for an average contribution of 64%. This
information suggests that when doses from dilute aqueous solutions are calculated
through Fick’s Law, and carefully considered, margins of safety may be significantly
more narrow than anticipated. On this basis, regulatory guidelines and policies may need
to be reconsidered (Brown, 1984).
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In another swimming pool exposure model, chlorinated pools were found to contain an
average of 156-500 mcg/L (156-500 ppb) chloroform contamination. A worst case
dermal exposure model was built utilizing Fick’s Law kinetics. Swimmers were assumed
to be totally immersed for three hours daily. During immersion, some absorption of the
aqueous chloroform was presumed to occur through the dermal and aural routes.
Accelerated dermal absorption would be expected from skin that has been freshly
wounded, abraded or sunburned. During some of the time the swimmer was immersed,
the internal tissues of the nose, mouth and eyes would also be exposed. For example,
about five milliliters of water is taken into the mouth and squirted out with each breath
when a child swims. In summary, dermal absorption from the dilute aqueous solution
represented 60% of the dose, as shown in the table below:
Table 7: Skin Absorption Rates of Chloroform in 500 ppb Aqueous Solution.
Route

Relative Absorption

Dermal

60%

Oral

3%

Buccal / Sublingual

3%

Orbital / Nasal

3%

Aural

3%

Inhalation

28%

(Beech, 1980).
An improved methodology to predict in vivo Kp values for dilute aqueous solutions
based upon molecular weight and oil-water partition coefficients was recently derived by
(Bogen, 1994) as follows:
Log10Kp

=

-0.812 – 0.0104 * MW + 0.616 * log10Kow

Kp

= (10^(-0.812 – 0.0104 * MW + 0.616 * log10Kow)) / 1000

Kp Toluene

= (-0.812 – 0.0104 * 92.1 + 0.616 * 2.73) / 1000

= .0008200 L/cm2/hr

Kp Chloroform

= (-0.812 – 0.0104 * 119.4 + 0.616 * 1.97) / 1000

= .0001400 L/cm2/hr

Kp Parathion

= (-0.812 – 0.0104 * 291.3 + 0.616 * 3.83) / 1000

= .0000300 L/cm2/hr
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cm/hr
L/cm2/hr

Kp Chlorpyrifos

= (-0.812 – 0.0104 * 350.62 + 0.616 * 4.70) / 1000 = .0000300 L/cm2/hr

Kp Malathion

= (-0.812 – 0.0104 * 330.36 + 0.616 * 2.75) / 1000 = .0000030 L/cm2/hr

Kp Malaoxon

= (-0.812 – 0.0104 * 314.36 + 0.616 * 2.02) / 1000 = .0000015 L/cm2/hr

Vertebrate Models. Vertebrate behavioral studies after exposure to dilute malathion
solutions are effective indicators of contamination and reflect sub-lethal toxicity. Because
behavior is an integrated result of endogenous and exogenous processes, behavioral
studies provide a way to address the question of effect in contaminant work. When using
fish as a bio-indicator, it has been suggested that a stressful condition is detected when
one or more physiological variables are altered to the point where long-term survival may
be impaired. Swimming behavior in fish is frequently assessed as a response in toxicity
investigations because altered locomotor activity can indicate effects to the nervous
system.
Fish were exposed to 20-50 mcg/L (20-50 ppb) dilute aqueous malathion solutions for 24
hours. Malathion exposure caused dramatic decreases in distance swam and swimming
speed as well as pronounced changes in complexity of swimming paths. A highly positive
correlation was found between 26% decreased brain cholinesterase activity and decreased
swimming speed. Significant fish mortality was found when the dilute aqueous malathion
solution concentration was increased to an 50 ppb exposure level and as a result caused
50% brain acetylcholinesterase inhibition (Cook 1976) (Brewer, 2001).
The sensitivity of vertebrate brain cholinesterase to malaoxon is as follows: sculpin fish >
chicken > sparrow > flounder > sunfish > bass > rat > mouse > monkey > duck >
bullhead > guinea pig. In summary, as far as brain cholinesterase sensitivity is concerned,
there is no clear grouping according to vertebrate class. However, sensitivity to poisoning
by malathion is as follows: fish > chickens > mice. Mouse liver hydrolyzes more than ten
times as much malathion as sunfish liver and about three times as much as chicken liver.
Therefore, the greater susceptibility of fish to poisoning by malathion can best be
accounted for on the basis of their relative inability to detoxify malaoxon (Murphy,
1968).
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Chapter Three
Medfly Eradication Exposure Data

Background. Certain malathion formulations are registered by EPA for aerial spraying
over urban areas in mosquito-control programs. The use of malathion in these programs
provides an important public health benefit by controlling mosquitoes that transmit
human disease (e.g. encephalitis, dengue fever, malaria). However, the spraying of
malathion bait over urban populations for Medfly eradication has generated controversy
in part because these applications are directed not at preventing human illness but at
eradicating an agricultural pest.
Federal law does not permit spraying malathion bait over urban areas without an
emergency EPA exemption. If and when the EPA grants said exemption, the responsible
government authorities post advance notification of spray schedules, schedule malathion
spraying episodes at night, and advise the public to stay indoors during spraying events
and wash any skin surface that may contact the malathion bait (Shafey 1999).
Aerial malathion bait may be used as a regulatory control method to establish freedom of
nursery or orchard premises from living fruit fly stages, as a condition for movement of
produce. To accomplish this, the establishment undergoes a series of treatments at
intervals, designed to provide continued freedom from fruit flies during the quarantine
period. Bait spray applications normally are limited to locations producing regulated
commodities within a quarantined area, but located outside the infested core area.
Treatments must start at a sufficient time, at least 30 days, before harvest (to span the
interval that normally would include the completion of egg, larval, and pupal
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development), then continue throughout the harvest period. The required pre-harvest
treatment makes this option useful for only those commodities remaining in the field for
more than 30 days after an area is quarantined (Smith, 2001).
Full foliar coverage bait spray of host trees and other plants immediately reduces fruit fly
populations by 90 percent or more and reduces subsequent reproduction. This decreases
fruit fly numbers in the succeeding generation and reduces the risk that gravid female
fruit flies will move to uninfested areas. In this manner, the malathion bait applications
reduce wild fruit fly populations to a level of infestation where mating thresholds are not
achieved or where continued releases of sterile fruit flies can be effective in reducing the
rest of the emerging pest population.
Technical Malathion. Numerous compounds are found in technical grade formulations of
pesticides. These co-products occur from breakdown or conversion of the active
ingredient, and from unintentional reactions occurring during pesticide synthesis.
Isomalathion is one of the largest potentiators of malathion toxicity, and is equipotent to
malaoxon. The in vivo mechanism of potentiation is inhibition of B-type
carboxylesterases (CEBs), the group of liver enzymes responsible for the metabolism of
malathion and malaoxon into their non-toxic alpha and beta monacids. Technical
malathion mixtures stored for extended periods of time under warm, humid conditions
may contain isomalathion at concentrations as high as 7%. Each one percent increase in
isomalathion content increases mammalian toxicity by an order of magnitude (Baker,
1978).
The concentration of technical malathion co-products varies from batch to batch, but the
major co-products are typically as shown in the following table.
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Table 8: Technical Malathion.
•

Isomalathion

0.20%

•

Malaoxon

0.10%

•

Diethyl fumarate

0.90%

•

O,O,S-trimethyl phosphorothioate [OOS(O) ]

0.04%

•

Diethyl methylthiosuccinate

1.00%

Concentrations of isomalathion in technical mixtures are generally quite low, rarely
exceeding 0.5% of the nominal malathion content. This conversion to isomalathion is
most prone to occur in water dispersible powders, where levels exceeding 3.0% are
common. Isomerization is a function of storage temperature, relative humidity, and
storage time. Increasing relative humidity from 41 to 65% increased the conversion rate,
as did storage for six months at 40C. The World Health Organization recommends that
technical malathion mixtures exceeding 1.8% isomalathion be discarded and not used.
Trimethyl phosphorothioates [OOS(O)] are present as impurities, reaction products and
breakdown products in technical grade malathion. OOS(O) is known as a potent inhibitor
of cholinesterases, beta-carboxylesterases, and neuropathy target esterases, especially
when reaching concentrations of 0.2-1.0% in the technical grade malathion mixture.
Diethyl fumarate is known as the causative agent of non-immunologic contact urticaria
(NICU) in humans. Skin irritation and rashes have been reported following malathionbait applications, both of which are symptomatic of NICU.
(Kizer, 1991).
Environmental Fate. Most organophosphate insecticides are used for crop spraying in
commercial agriculture. Approximately 75% of all insecticides are used for cotton, corn
and soybeans. Malathion is the most widely used organophosphate insecticide.
Organophosphate compounds degrade in the environment at varying rates: half-lives
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range from days to months, although generally half-lives are longest in dry climates and
low temperature.
Soil. Malathion is of low persistence in soil with field half lives of up to 25 days.
Degradation in soil is rapid and related to the degree of soil binding. Breakdown occurs
by a combination of biological degradation and non-biological reaction with water. If
released to the atmosphere, malathion will breakdown rapidly in sunlight, with a reported
half-life in air of about 1.5 days. It is moderately bound to soils, and is soluble in water,
so it may pose a risk of groundwater or surface water contamination in situations which
may be less conducive to breakdown.
Water. Malathion when dissolved in bodies of water is readily oxidized to malaoxon by a
variety of mild oxidizing reagents. Thus, it is generally recognized that malathion is
easily oxidized to malaoxon by swimming pool chlorine concentrations. For example,
malaoxon has greatest persistence when pool water is acidic, and malathion is stable in
oxygen saturated water at acidic pH for up to two weeks. Sunlight shortens malathion and
malaoxon half-lives in pools to 3 days. These data suggest that little accumulation of
malathion or malaoxon in swimming pools occurs, but does indicate that they can persist
at low levels for a considerable period of time.
In river water, the half-life of malathion is generally less than one week. For example, in
the Suwanee River with large amounts of tannins, malathion was 50% degraded by
sunlight within 16 hours. However, malathion may remain stable in distilled water for
three weeks and its photolysis half-life is 41 days. Applied at up to 6 pounds per acre in
log ponds for mosquito control, it is generally effective for 2.5-6 weeks. In seawater,
degradation increases with salinity. Breakdown products in acidic water are mono- and
dicarboxylic acids such as dimethyl phophorothionic acid and 2-mercaptodiethyl
succinate (Howard, 1991) (Wolfe, 1975).
Hydrolysis of malathion in basic pH aqueous solution yields primary breakdown products
diethyl fumarate and dimethyl phophorodithioic acid (DMPTA). At pH 8.0, diethyl
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fumarate remains stable for 1.5-4 days. In the fathead minnow animal model, two-way
and three-way interactions of the breakdown products caused large synergistic increases
in toxicity. In particular, diethyl fumarate could be produced as a breakdown product in
significant quantities in basic pH aqueous solutions to produce synergistic toxic effects
with malathion in vivo (Cook, 1976).
Air. Malathion bait is oxidized rapidly in the atmosphere by ozone and dinitrogen
tetraoxide to malaoxon, but not by molecular oxygen. Thus, two days post-spray
application the outdoor air concentration of malaoxon generally exceeds that of
malathion. Air concentrations of malathion also increase at two days post-spray
application by volatilization of the bait droplets. Outdoor particle diameter is ~100 um
with particles ranging up to 350 um. Indoor particle diameter is ~3 um and lower, evenly
distributed on walls, ceilings and floors. Malathion bait found indoors is 3% of the
amount found in the adjacent outdoor area (Caplan PE, 1956) (Kizer, 1991).
Hillsborough County, Florida, 1997.

Medfly eradication commenced via aerial

malathion protein bait application on June 5, 1997. About 2.4 ounces by weight of
malathion with 9.6 ounces of corn syrup protein bait was targeted to each acre in the
quarantine area. About 2.6 mg/ft2 of malathion was targeted into nine square mile areas
centered around each Medfly find. During the ten week time period under study, thru
August 1997, vintage military aircraft sprayed 31,000+ gallons of malathion bait over
400+ square miles of Hillsborough County landscape. One million people lived and
worked in the aerial spray zone areas (Smith, 2001).
This malathion bait concentration transferring from the air into a one meter deep body of
water typically yields a 22 ppb dilute aqueous solution. Importantly, however, bait spray
applications are made at 5-10 day intervals until eradication is achieved. Certain areas in
Lakeland, for example, were sprayed at least 8 times. As a result, large fluctuations in
concentration are known to have occurred in “Medfly hot zones”, DC-3 flight pattern
overlapping zones, and bodies of water subject to storm-water runoff.
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A registry for people reporting increased health problems associated with the malathion
spray program was established. The “Malathion Health Survey” is a cooperative effort
between the USF College of Public Health, Poison Control Center, and Hillsborough
County Health Department. As of 10/6/97, more than 700 calls from people reporting
exposure to malathion had been received.

Most reported some kind of symptoms,

including nausea and headaches.
The Tampa Tribune has featured possible victims with adverse reactions temporally
related to the application of malathion bait:
(1) A 7yo diver and swimmer had 3 days of headache, nausea and sore throat when
practicing the day after a DC-3 sprayed malathion in and around Brandon Swim
and Tennis Club (BSTC) pool. The swimming pool was found the day after
spraying to have 12 ppb malaoxon contamination;
(2) An elementary school teacher sprayed with malathion on campus had a rash;
(3) A restaurant worker caught in the path of a DC-3 had nausea and chest pain;
(4) Three children had blisters/rashes on shoulders/arms and diarrhea after playing in
a Riverview lime tree the day after malathion spraying;
(5) A man’s arm had angry red rash when immersed in family pool 3 hours after
malathion spraying.
Only limited environmental sampling has been accomplished during the aerial application
of malathion spray in Hillsborough County. The Environmental Protection Commission
(EPC) of Hillsborough County has published a limited number of water sample results as
follows:
Table 9: Tampa Swimming pool sampling by FL-EPC (ppb).
•

Malathion- range 0- 1;

mean 0.

•

Malaoxon- range 1-19;

mean 5.

•

Malaoxon at BSTC on Day 0=24 ppb; Day 1=12ppb; Day 2=5ppb; Day 3=2.5ppb.

•

BSTC Swim and Diving Team (n=15-20): 33-50% became ill when swimming the
day after aerial application of malathion bait to the swimming pool area.
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Table 10: Tampa Pond sampling by FL-EPC (ppb).
•

Malathion- range 21-79;

mean 49.

•

Malaoxon- range 00-01;

mean 01.

•

Malathion city water treatment plant = 0.7, and malaoxon = 0.5.

•

Malathion at Riverview apartment pond = 25.

•

Malathion at Alafia River = 12.

•

Malathion at six fish kill sites = 2.3-25.0.

Dade, Lake, Marion, Manatee and Highland County, Florida, 1998. During the spring
and summer of 1998, aerial malathion and ground diazinon application was used by
federal and state agriculture authorities to eradicate Medfly infestations that had been
detected in portions of five Florida counties. All insecticide application was complete on
September 6 with an estimated 132,000 persons residing in the pesticide treatment area.
Reports of potential adverse health effects attributed to the Medfly Eradication Program
were solicited by state health and agriculture authorities. During the Spring and Summer
months, 230 reports of illness were investigated and classified by the Florida Department
of Health as outlined in the following table.
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Table 11: Medfly Spray-related Adverse Events, Florida Department of Health.
•

Probable: 34 (15%), based upon abnormal medical signs observed by a licensed
health-care professional;

•

Possible: 89 (39%), based upon abnormal symptoms compatible with
organophosphate toxicity reported to health-care workers or a state health
authority.

•

Probable plus Possible: 123 (54%), or crude incidence rate of 9 / 10,000 residents;

•

Eight reports involved children < 5yo;

•

Twenty reports involved elderly > 65yo;

•

Four reports involved work-related illnesses such as pesticide applicators;

Of the signs and symptoms reported in the “Probable plus Possible” group:
•

71% were respiratory (dyspnea, wheezing, coughing);

•

63% were gastrointestinal (cramping, nausea, vomiting, diarrhea);

•

60% were neurologic (headache, vertigo, ataxia, paresthesia, confusion);

•

23% were dermatologic (erythema, rash, pruritis);

•

23% were ophthalmic (lacrimation, conjunctivitis, blurred vision).

In the case reports, specific exposures were reported while:
•

Conducting lawn maintenance business, where grass trimmings stuck to skin;

•

Working on roof of house;

•

Removing pool cover, which was folded and carried under sleeveless arm.

(Shafey, 1999).
Los Angeles, California, 1990. In California, more extensive environmental sampling has
shown the amount of malathion bait actually sprayed on some occasions was 40-350%
more than would be predicted from uniform coverage calculations:
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Table 12: Los Angeles Swimming pool sampling by CA-EPA (ppb).
•

Malathion- range 4-90;

mean 18.

•

Malaoxon- range 0-46;

mean 16.

•

Malaoxon was found in two pools one week after application at 7 ppb.

Table 13: Los Angeles Pond sampling by CA-EPA (ppb).
•

Malathion- range 21-79;

mean 49.

•

Malaoxon- range 00-01;

mean 01.

Table 14: Los Angeles Storm-water runoff by CA-EPA (ppb).
•

Malathion- range 0-703;

mean 151.

•

Malaoxon- range 0- 18;

mean

2.

In summary, there is solid evidence for potential toxic exposure to malathion and its coproducts while swimming in outdoor bodies of water during and after aerial malathion
bait application. Furthermore, Los Angeles County exposure data has found swimming
malathion pool contamination as high as 90 ppb. Many malathion bait spray scenarios
may converge to account for high environmental concentrations: e.g. physical-chemicalbiological reactions; over-lapping spray areas; repeat spray areas, human error; technical
limitations; and weather fluctuations.
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Chapter Four
Hazard Index
The aerial application of malathion bait results in exposure by three routes: inhalation,
ingestion, and dermal absorption. Exposure may be acute, sub-acute, or chronic in nature.
Exposure to malathion and/or its three significant co-products, isomalathion, malaoxon,
and diethyl fumarate, may occur depending upon the specific scenario under study. The
scope of this analysis will focus only upon an adult and child’s acute dermal exposure to
dilute aqueous concentrations of malathion and one of its co-products, malaoxon, while
immersed in a contaminated swimming pool after a typical aerial malathion bait spray
episode.
In presenting exposure and dosage scenarios, the concept of reference exposure level
(REL) is utilized: the level at which no adverse health effects are anticipated. Therefore,
health protection is achieved if the estimated dosage is below the relevant REL. In order
to make REL data easier to interpret, a Hazard Index (HI) format is chosen, where HI =
(estimated dosage / REL). Note that hazard index > 1 represents possible exposure
scenarios greater than the relevant REL. Estimated dosages > REL or hazard indexes > 1
are not necessarily hazardous, and do not absolutely result in significant health effects;
however, further analysis may be warranted.
Several independent studies and guidelines are available to define the “incipient toxicity”
level for malathion exposure. In the best available study, depression of cholinesterase
activity was observed two weeks after the oral administration of malathion 24 mg to five
human subjects for 55 consecutive days. Maximum depression of plasma cholinesterase
activity (25%) and red blood cell (RBC) cholinesterase activity (30%) occurred three
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weeks after cessation of malathion. In spite of the depression in both plasma and RBC
cholinesterase activity, no clinical side effects were observed. In summary, this report
agrees with the State of CA assessment of about 0.2 mg/kg/day as the preliminary REL.
The best available approach for estimating dermal exposure to malathion in a swimming
pool is the model utilized for chloroform (CF) and trichloroethylene (TCE) for baths and
showers. This type model is specific for dilute aqueous solutions of lipophilic, organic
contaminants.
In vitro and in vivo measurements of CF and TCE uptake by human skin from dilute
aqueous solution indicate that short-term, non-steady-state, dermal uptake kinetics are
consistent with a first-order partition model. The first-order partition coefficient
estimation assumes that the stratum corneum is the effective skin compartment volume of
distribution, as it likely is with most lipophilic, organic compounds such as malathion.
Blood perfusion to skin is likely to cause relatively rapid equilibrium of chemical
concentrations within the epidermis, and perhaps within the underlying dermal tissue as
well. This scenario is expected particularly in the shower, bath and swimming pool
scenarios, involving relatively high water temperatures known to elicit a ten fold increase
in local dermal blood perfusion rates (Bogen, 1995).
For example, Bogen’s method can be utilized, with some key assumptions, to derive an
exposure estimate for a child in a contaminated swimming pool model as follows:
Ds = Kp*Dc*De*Fs*As*Sys / Mb
Where:
•

Ds = systemic dose rate in mg/kg/day

And:
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•

Kp-malathion = permeability constant across the skin = 0.001 L/cm2/hr;

•

Dc = concentration of malathion in water

= 30 mcg/L or 30 ppb;

•

De = duration of contact with contaminated water

= 3 hr;

•

Fs = fraction of skin in contact with water

= 1.0;

•

As = exposed skin surface area

= 12 000 cm2;

•

Mb = body mass

= 34.5 kg;

•

Sys = Dermal absorption to Systemic Absorption

= 0.10.

The dermal absorption to systemic absorption conversion factor (Sys = 0.10) is an
important parameter that deserves further explanation. This factor is derived from
Maibach’s three human studies of non-occlusive, concentrated dermal malathion
absorption versus Dary’s contrasting occlusive study of human forearms utilizing dilute
malathion aqueous solution exposures (Webster and Maibach, 1983) (Feldmann and
Maibach, 1974) (Maibach, 1971) (Dary, 1994). Dary determined that 15% of the initial
applied dose is systemically absorbed and eliminated in urine, but this figure may be
adjusted downward towards Maibach’s figures (4%, 8%, and 7%) to account for the nonocclusive setting of the swimmer. That is, it is assumed that swimmers first shower with
soap and water after three hours of swimming, in effect mechanically removing
malathion from the skin surface-epidermis layer, then secondly move into environmental
settings conducive to dermal layer evaporation over the remainder of the day.
Assuming Kp-malathion is reasonably estimated from similar Fick’s Law studies of
ethylbenzene, toluene, styrene, and xylene in dilute aqueous solutions, the specific dose
rate in a swimming pool with contamination of 30 ppb malathion to a 7 yo child during a
3 hour work-out is about: 0.003 mg/kg/day, or 0.1 mg total. Thus, swimming pool
exposure to malathion in this model is about 70 times less than the REL, yielding a
hazard index of 0.015. These preliminary data, with key assumptions, indicate that
exposure to aqueous malathion at this concentration in this model is not appreciably
absorbed, and therefore, it is not a public health hazard.
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Chapter Five
Significance of Research
It is interesting to note that many factors in a swimming pool exposure model may
actually enhance Kp over published values. For example, increased water retention in the
stratum corneum layer, increased skin surface temperature and increased skin blood flow
from exercise all tend to increase Kp. For lipid soluble substances like malathion,
lowered viscosity of tissue lipids at higher temperatures reduces activation energies for
diffusion. In addition, sunburned or wounded skin accelerates dermal absorption.
Finally, skin sites in children appear to be more permeable than skin sites in adults. Most
of these factors are operational in the swimming pool model in a way that tends to
increase the dermal absorption of malathion.
Nevertheless, the main area of uncertainty in the swimming pool exposure model is
within the estimate for Kp-malathion. Unfortunately, specific experimental data for Kpmalathion

do not exist. Fortunately, Kp has been determined for similar compounds in dilute

aqueous solutions such as ethylbenzene, styrene, and toluene, all of which were
determined to have similar values to the Kp used for malathion above. Further
experimental determination of Kp-malathion as used in Bogen’s dermal exposure equations is
necessary before models for toxic exposures in dilute aqueous solutions of malathion
while bathing are convincing.
The balance of malathion and malaoxon exposure in humans may be swayed by
concomitant exposure to exogenous malaoxon. Swimmers may be exposed to malaoxon
in addition to malathion as the aerial bait lands in the swimming pool and is oxidized by
its chlorine to this much more potent active metabolite. Let’s recalculate the dermal
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absorption for the 7yo swimmer, except this time assuming exposure to 30 ppb malathion
+ 30 ppb malaoxon.
Ds = Kp*Dc*De*Fs*As *Sys/ Mb
Note that the chosen concentrations of malathion and malaoxon are within one standard
deviation of the mean actual California swimming pool data, and are both well within the
UCL values. In addition, let’s use potency of malaoxon = 68 * malathion.
•

Kpmalathion = permeability constant across the skin

= 0.0010 L/cm2/hr;

•

Kpmalaoxon = permeability constant across the skin

= 0.0005 L/cm2/hr;

•

Dc = concentration of malathion in water

= 30 mcg/L or 30 ppb;

•

Dc = concentration of malaoxon in water

= 30 mcg/L or 30 ppb;

•

De = duration of contact with contaminated water

= 3 hr;

•

Fs = fraction of skin in contact with water

= 1.0;

•

As = exposed skin surface area

= 12 000 cm2;

•

Mb = body mass

= 34.5 kg;

•

Sys = Dermal absorption to Systemic absorption

= 0.10.

Assuming Kp-malathion and Kp-malaoxon are reasonable, the specific dose rate in a swimming
pool with contamination of 30 ppb malathion and 30 ppb malaoxon to a 7 yo child during
a 3 hour work-out is about: 0.11 mg/kg/day, or about 3.8 mg total. Important assumptions
in this first pass analysis include swimmers first showering with soap and water after
three hours of swimming, in effect mechanically removing malathion and malaoxon from
the skin surface-epidermis layer, then secondly moving into environmental settings
conducive to dermal layer malathion and malaoxon evaporation over the remainder of the
day. This swimming pool model dosage for malathion + malaoxon is about half the
adjusted REL, yielding HI = 0.5. Therefore, by definition, this dose may be sufficiently
close enough to HI = 1 to cause a specific ailment or disease related to malathion toxicity,
and further analysis is warranted.
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Chapter Six
Methods
Background: Historical studies have measured human dermal uptake of related aromatic
chemicals from aqueous solutions, using the “disappearance method” in concert with the
analysis of excreted metabolites. In all the studies that examined uptake from aqueous
solutions using the disappearance method, both whole hands of each person was
immersed for two hours in a one-liter beaker. For example, disappearance measurements
of aqueous ethylbenzene at 125 ppm were compared to the absorbed amount computed
by utilizing the urine metabolite mandelic acid. Chemical flux into skin was validated as
the difference in chemical mass contained in the exposure solution at the beginning and
end of the exposure period, divided by the corresponding dermal surface area
(Dutkiewicz and Tyras, 1967).
Design: Prospective, controlled, and limited dermal exposure of hands and forearms of
human volunteers to dilute aqueous solutions of 50-ppb (mcg/l) malathion in a laboratory
setting.
Measurements: EPA-approved, commercial assays to 0.5-ppb (mcg/l) malathion will be
utilized in order to measure the concentrations in water before and after hand and forearm
exposure.
Subjects: Twenty volunteers
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Test Solution: Twenty liter tanks were prepared with dilute aqueous solutions of 50-ppb
(mcg/l) malathion. The solution was prepared by placing 1 mg of laboratory grade
malathion (Supelco PS86, Malathion, Neat) into the distilled water bath.
A Standard Operating Procedure (SOP) was carefully developed, documented and
verified to ensure volunteer subject safety. Several quality assurance based trial runs were
undertaken prior to the first volunteer subject exposure period. During each trial run, each
twenty liter tank prepared under the SOP was verified to contain a 50-ppb malathion
concentration via an EPA-approved, commercial assay sensitive to 0.5 ppb. During the
quality control evaluation period, the tank malathion concentrations were verified to be
within ±30% (±15 ppb) of the nominal target concentration (50 ppb or 50 mcg/L).
The malathion exposure tank was stagnant, hand-stirred, and then mechanically stirred
during three different stirring exposure phases of the protocol. The tanks were at room
temperature (21°C) and swimming pool temperature (29°C or 90°F) during two different
temperature exposure phases of the protocol as well. Volunteer exposure time was
gradually increased during several different phases of the protocol from 30 minutes to
120 minutes. All upward adjustments in exposure level were carefully made in series to
ensure maximum volunteer safety.
Method: Subjects place both hands and forearms (total body surface area: Fs = 0.11) into
a dilute aqueous 50-ppb (mcg/l) malathion solution for up to two (2) hours. Malathion
solution assays are then made via the “disappearance method” on the tank solution before
and after the exposure period.
Malathion assays are completed by passing the tank exposure solution through
Bakerbond C18 Speedisks (Part Number 8055-06). Five hundred milliliters of the
exposure solution is drained through the Speedisk via full vacuum suction (about 25 mm
Hg) applied to a Speedisk extraction station (for about five minutes). The Speedisks with
extracted malathion solute were then shipped in a sealed container to Ecology and
Environment, Inc., for completion of the EPA assay method.
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Precise concentrations in the dilute aqueous malathion solution were determined before
and after exposure using EPA SW-846 Method 8270C at Ecology and Environment, Inc
(Lancaster, NY). This EPA-approved commercial assay method is sensitive to 0.5 ppb.
The semi-volatile compound is introduced from a sample extract into the gas
chromatograph by direct injection of 2 mcl of the extract. Sample extracts are prepared
for analysis by transferring a measured aliquot of extract to an autosampler vial and
adding the appropriate amount of internal standard solution. Chromatographic conditions
are such that the compounds are separated by the gas chromatograph. The compounds are
detected using a mass spectrometer from which both qualitative and quantitative
information is obtained. Quantitation is by the internal standard technique using relative
response factors.
Calculations of chemical flux into skin from the exposure solution are estimated
according to Fick’s Law as the difference in chemical mass contained in the exposure
solution at the beginning and end of the exposure period, divided by the corresponding
exposed dermal surface areas. In summary, a Mass Balance System was implemented
upon the exposure solution, with the assumption that all lost malathion in solution was
driven down the concentration gradient into the exposed human subject. Kp-malathion
(permeability constant across the skin) was then derived from the actual Fs=0.11
exposure model. Kp-malathion was then theoretically applied to an Fs = 1.00 swimming pool
model for both theoretical child and adult swimming pool models. Finally, hazard index
(HI) for theoretical three-hour swimming pool exposures were calculated based upon
experimentally derived Dd and Kp-malathion values.
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Table 15: Parameters for Kp = Dd*Mb / (Dc*De*Fs*As).
•

Dd = skin dosage of malathion absorbed in mcg

•

Dc = average concentration gradient of malathion from water to skin

•

De = duration of contact with contaminated water

•

Fs = fraction of skin in contact with exposure solution

= 0.11;

•

Fsadj = adjustment for Maibach’s relative skin absorption

= 0.0775;

•

Fs = fraction of skin in contact with water in swimming pool

= 1.00;

Table 16: Parameters for Ds = Kp*Dc*De*Fs*As*Sys / Mb.
Adult:
•

As = total skin surface area

= 21 345 cm2;

•

Mb = body mass

= 85 kg;

•

HI = Ds / (0.2 mg/kg/day)*(85 kg)

= Ds / 17 mg;

•

As = exposed skin surface area

= 12 000 cm2;

•

Mb = body mass

= 34.5 kg;

•

HI = Ds / (0.2 mg/kg/day)* (34.5 kg)

= Ds / 7 mg;

Child:

Example Calculation: Utilize the theoretical exposure model Dd = Kp*Dc*De*Fs*As /
Mb, and assume approximate Kp-malathion = 0.001 L/cm2/hr. An 85 kg subject typically has
hand area Fs=.025 (each) and forearm area Fs=.03 (each). Therefore, immersing both
hands and forearms in the malathion solution yields a total exposure area Fs=.11, with
Fsadj = 0.0775 after adjustment for Maibach’s relative skin absorption data. Therefore,
this theoretical volunteer would dermally, but not systemically, absorb:
Dd = (.001 L/cm2/hr)(50 ppb or mcg/l)(3 hr)(.0775)(21 345 cm2) = 248 mcg.
The 20 liter immersion tank, then, would change from the original concentration of 50
ppb malathion to 37.6 ppb (mcg/l) or (1000 mcg - 248 mcg) / 20 liters. This change in
malathion concentration over the time period of the volunteer subject exposure period is
well within the sensitivity of the NIOSH/EPA laboratory assay procedure.
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Chapter Seven
Volunteer Safety
Screening of Volunteer Subjects:

Each female participant had a proven negative

pregnancy test within 72 hours of study participation. Each volunteer subject was
screened for a history of acute or chronic disease or disability, Gulf War Syndrome, or
previous significant exposure to malathion, organophosphate or other pesticide. If the
screening history is positive, the subject is eliminated from participation in the study
protocol.
Medical Observation: Each subject is intermittently observed for acute cholinergic signs
and symptoms by a licensed physician during the two (2) hour experimental protocol
period as follows:
•

Mild exposure symptoms include headache, giddiness, dizziness, anxiety, weakness,
tremors of tongue and eyelids, and miosis.

•

Moderate exposure symptoms include behavioral disturbances, sweating, nausea,
vomiting, salivation, lacrimation, diarrhea, paresthesias, muscle tremors, and incoordination.

•

Severe exposure symptoms include fecal and urinary incontinence, pulmonary edema,
heart block, respiratory failure, convulsions, coma and death.

Although highly unlikely at the malathion dosage selected for use in this experimental
protocol, a volunteer exhibiting signs or symptoms of organophosphate exposure would
be referred to a local emergency room for treatment at once. In addition, a resuscitation
cart equipped for atropine and pralidoxime (2-PAM) administration was immediately
available

for

use

by

a

licensed

physician
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should

emergency

reversal

of

cholinergic events become necessary. Furthermore, volunteers exhibiting any cholinergic
signs or symptoms would be reported as an adverse event to the Institutional Review
Board at once.
Hazard Index Model: Worst-case-scenario analysis assumes the subject volunteer
absorbs all the malathion in the exposure tank, 1 mg, or 12 mcg/kg/day. Since the
Reference Exposure Level is 200 mcg/kg/day, Hazard Index = 12/200 or 0.06. Therefore,
health protection is achieved since the estimated dosage is an order of magnitude below
the relevant REL and HI << 1.
Biological Exposure Indices: The ACGIH recommended BEI for organophosphorus
cholinesterase inhibitors (e.g. malathion) is RBC Cholinesterase Activity. Significant
exposure is widely recognized to have occurred if RBC Cholinesterase activity is
decreased more than 30% from an individual’s baseline condition. Continued depression
may occur in dose-dependent fashion for up to 12 weeks post-exposure. RBC
cholinesterase activity is the preferred measure as it is the same enzyme found within the
nervous system.
In Moeller and Rider’s NOAEL / LOAEL landmark malathion study, the defined
objective was to determine the maximum amount of malathion which can be ingested
daily for a prolonged period of time without depressing the pretest level of RBC
Cholinesterase Activity. The subjects were healthy men in San Quentin State Prison.
Malathion was orally administered at 8 mg/day for 32 days, 16 mg/day for 47 days, and
24 mg/day for 56 days. RBC Cholinesterase was analyzed at baseline then twice weekly.
Neither 8 mg/day nor 16 mg/day affected RBC Cholinesterase Activity in a statistically
significant manner. However, 24 mg/day for 56 days depressed RBC Cholinesterase
Activity to about 75% of baseline.
Based upon Moeller and Rider’s study, BEI monitoring with RBC Cholinesterase
Activity during this protocol appears unwarranted. That is, in the worst case scenario, the
volunteer subject would absorb all the malathion in the exposure tank: 1 mg. This dosage
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is well below the known dosage to cause RBC Cholinesterase depression. Furthermore,
volunteer subjects in this protocol have only a single exposure. In the Moeller and Rider
study, volunteer subjects required 24 mg oral ingestion exposures on 56 consecutive days
before RBC Cholinesterase was depressed.
Dermal Exposure Indices: Dermal absorption of neat malathion (24.6 mg), a 50%
emulsifiable concentrate (25.7 mg), and a 1% (0.16 mg) and 10% (5.5 mg) aqueous
mixture was examined in human volunteers. Each volunteer subject received a single
application of the nominal dose of malathion applied to a 4.6 cm2 area of the ventral
forearm. The 1.0% aqueous mixture appeared to be more readily absorbed than the other
formulations: 6.42% of the external concentration was absorbed per hour (Dary, 1994).
Based upon this study analysis, <20% of the dilute malathion aqueous experimental
solution will be absorbed after 2 hours time by the volunteers, or about 0.2 mg of
Malathion. This dosage of malathion is well under the Reference Exposure Level (REL)
and Hazard Index (HI) for Malathion
Theoretical Mathematical Exposure Model: Utilizing the exposure model described once
again

with

assumed

Kp-malathion =0.001

L/cm2/hr,

and

the

formula

Ds

=

Kp*Dc*De*Fsadj*As*Sys / Mb, the subject volunteers in the protocol will be exposed to
about:
Ds

= (.001 L/cm2/hr)(50 ppb)(3 hr)(.0775)(21 345 cm2)(0.10) / (85 kg);
= 25 mcg / 85 kg adult;
= 0.3 mcg/kg/day.

Reference Exposure Level (REL) = 200 mcg/kg/day;
Hazard Index (HI) = 0.3 / 200 = 0.0015.
Therefore, health protection is achieved since the estimated dosage is below the relevant
REL and the HI is << 1.
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Over-the-counter Exposure Model: Household over-the-counter malathion formulations
(Spectracide®, manufactured for Spectrum Group, United Industries Corporation, St.
Louis, EPA Reg. No. 10370-291-8845) are available in 50% xylene solution, or 500
mg/ml. The worst-case-scenario exposure of a subject volunteer in this protocol is
equivalent to exposure to about 1/500 ml or 0.002 ml of the over-the-counter solution.

Carcinogen Status: At the time of the study protocol approval, malathion was not
classified as a carcinogen by any certified organization including the ACGIH.
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Chapter Eight
Results

Table 17: General Experimental Results.
•

Demographics: All volunteer subjects were between ages 25-50 yo, weight 70 –
100 kg, and 2/20 (10%) were female.

•

Subject eleven was removed from further data analysis due to the null
concentration of malathion during the exposure period.

•

Eight of nineteen subjects (42%) absorbed no malathion from solution, thus
receiving no malathion dosage during exposure.

•

Eleven of nineteen subjects (58%) absorbed malathion from solution, thus
receiving a malathion dosage during exposure.

•

Begin versus end malathion concentrations were highly variable from volunteer to
volunteer, but not significantly different (p = 0.185).

•

Volunteer

Safety:

No

volunteer

experienced

signs

or

symptoms

of

organophosphate exposure or toxicity at any time.
•

Experimental Kpmalathion derived from human volunteer exposures ranged from 0 0.0051 L/cm2/hr (ave=0.0005, SD=0.0011, UCL=0.0028).

•

Hazard Index (HI) for adult swimmers immersed for three hours in Malathion=30
ppb+Malaoxon=0 ppb (utilizing experimentally-derived Kpmalathion) ranged from 0
– 0.06 (ave=0.01, SD=0.01, UCL=0.03).

•

Hazard Index (HI) for child swimmers immersed for three hours in Malathion=30
ppb+Malaoxon=0 ppb (utilizing experimentally-derived Kpmalathion) ranged from 0
– 0.08 (ave=0.01, SD=0.02, UCL=0.04).

53

•

Hazard Index (HI) for adult swimmers immersed for three hours in Malathion=30
ppb+Malaoxon=30 ppb (utilizing experimentally-derived Kpmalathion) ranged from
0 – 2.0 (ave=0.21, SD=0.45, UCL=1.11).

•

Hazard Index (HI) for child swimmers immersed for three hours in Malathion=30
ppb+Malaoxon=30 ppb (utilizing experimentally-derived Kpmalathion) ranged from
0 – 2.8 (ave=0.29, SD=0.62, UCL=1.53).

Malathion (mcg)

Table 18: Dermal Absorption by Volunteer - I
400
350
300
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200
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0
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Table 19: Dermal Absorption by Volunteer - II
0.006
0.005
0.004
0.003
0.002
0.001
0
1

2

3
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5

6

7

8

9

10 11 12 13 14 15 16 17 18 19 20

Volunteer Number

54

Frequency
(# volunteers)

Table 20: Dermal Absorption by Dosage
9
8
7
6
5
4
3
2
1
0
Zero

1 to 40 41 to 80

81 to
120

121 to
160

161 to
200

201 to
240

241 to
280

281 to
320

321 to
360

Malathion (mcg)

Frequency
(# volunteers)

Table 21: Dermal Absorption by Kp-malathion
9
8
7
6
5
4
3
2
1
0
zero

1 to 5

6 to
10

11 to
15

16 to
20

21 to
25

26 to
30

31 to
35

Kp-malathion x 104 (L/cm2/hr)

55

36 to
40

41 to
45

46 to
50

51 to
55

Table 22:

Hand / Forearm Exposure in Aquarium;
Nominal Contamination: Malathion=50 ppb + Malaoxon=0 ppb;
Disappearance Method: Solution Concentrations.

subject

pre-

post-

stir

temp

time

malathion

malathion

(mcg/l)

(mcg/l)

(°C)

(min)

1

38.6

31.2

no

21

30

2

51.6

52.6

no

21

60

3

46.8

43.6

no

21

60

4

40.4

37.2

no

21

90

5

42.4

44.0

no

21

90

6

50.0

48.4

no

21

90

7

39.2

36.6

no

21

135

8

32.4

34.8

no

21

135

9

47.2

45.6

no

21

135

10

68.0

60.0

yes

21

120

11

0.0

0.0

yes

21

120

12

126.0

108.0

yes

21

120

13

46.0

46.0

yes

21

120

14

46.0

46.0

yes

21

120

15

44.0

46.0

yes

21

120

16

50.0

48.0

yes

29

120

17

56.0

52.0

yes

29

120

18

34.0

48.0

yes

29

120

19

50.0

50.0

yes

29

120

20

50.0

44.0

yes

29

120

56

Table 23:

Hand / Forearm Exposure in Aquarium;
Nominal Contamination: Malathion=50 ppb + Malaoxon=0 ppb;
Disappearance Method: Experimental determination of Kpmalathion.

subject

Skin

Kp-malathion

Dosage
(Dd in mcg)

(L/cm2/hr)

1

148

.00513

2

0

3

64

.00086

4

64

.00067

5

0

6

32

.00026

7

52

.00037

8

0

9

32

.00019

10

160

.00076

11

0

12

360

13

0

0

14

0

0

15

0

0

16

40

.00025

17

80

.00045

18

0

0

19

0

0

20

120

0

0

0

0
.00093

.00077

57

Table 24:

Swimming Pool Model using experimental Kpmalathion;
Contamination: Malathion=30 ppb + Malaoxon=0 ppb;
Adult Swimmer immersed for three hours.

subject

Skin

Systemic

Hazard

Dosage

Dosage

Index

(Dd in mg)

(Ds in mg)

1

9.85

1.0

0.06

2

0

0

0

3

1.64

0.2

0.01

4

1.28

0.1

0.01

5

0

0

0

6

0.50

0.05

0.003

7

0.71

0.1

0.004

8

0

0

0

9

0.36

0.04

0.002

10

1.45

0.1

0.01

11

0

0

0

12

1.79

0.2

0.01

13

0

0

0

14

0

0

0

15

0

0

0

16

0.47

0.05

0.003

17

0.86

0.1

0.005

18

0

0

0

19

0

0

0

20

1.48

0.1

0.01
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Table 25:

Theoretical Swimming Pool Model using experimental Kpmalathion;
Contamination: Malathion=30 ppb + Malaoxon=0 ppb;
Child Swimmer immersed for three hours.

subject

Skin

Systemic

Hazard

Dosage

Dosage

Index

(Dd in mg)

(Ds in mg)

1

5.54

0.5

0.08

2

0

0

0

3

0.92

0.1

0.01

4

0.72

0.1

0.01

5

0

0

0

6

0.28

0.03

0.004

7

0.40

0.04

0.006

8

0

0

0

9

0.20

0.02

0.003

10

0.82

0.08

0.01

11

0

0

0

12

1.00

0.1

0.01

13

0

0

0

14

0

0

0

15

0

0

0

16

0.27

0.03

0.004

17

0.48

0.05

0.007

18

0

0

0

19

0

0

0

20

0.83

0.08

0.01

59

Table 26:

Theoretical Swimming Pool Model using experimental Kpmalathion;
Contamination: Malathion=30 ppb + Malaoxon=30 ppb;
Adult Swimmer immersed for three hours.

subject

Skin

Systemic

Hazard

Dosage

Dosage

Index

(Dd in mg)

(Ds in mg)

1

345

34.5

2

0

0

0

3

57

5.7

0.3

4

45

4.5

0.3

5

0

0

0

6

18

1.8

0.1

7

25

2.5

0.2

8

0

0

0

9

12

1.2

0.1

10

51

5.1

0.3

11

0

0

0

12

63

6.3

0.4

13

0

0

0

14

0

0

0

15

0

0

0

16

17

1.7

0.1

17

30

3.0

0.2

18

0

0

0

19

0

0

0

20

52

5.2

0.3

2.0
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Table 27:

Theoretical Swimming Pool Model using experimental Kpmalathion;
Contamination: Malathion=30 ppb + Malaoxon=30 ppb;
Child Swimmer immersed for three hours.

subject

Skin

Systemic

Hazard

Dosage

Dosage

Index

(Dd in mg)

(Ds in mg)

1

194

19

2

0

0

0

3

32

3.2

0.5

4

25

2.5

0.4

5

0

0

0

6

10

1.0

0.1

7

14

1.4

0.2

8

0

0

0

9

7

0.7

0.1

10

29

2.9

0.4

11

0

0

0

12

35

3.5

0.5

13

0

0

0

14

0

0

0

15

0

0

0

16

9

0.9

0.1

17

17

1.7

0.2

18

0

0

0

19

0

0

0

20

29

2.9

0.4

2.8
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Chapter Nine
Discussion
It is not uncommon in dermal absorption studies for wide Kp variation within individual
experimental results. Absorption constants and as a result dosage received can vary by
several orders of magnitude between human subjects. For example, during this protocol,
eight of nineteen subjects absorbed nil malathion, or at least so little that no absorption
could be detected by the disappearance technique. In contrast, the absorption constant
derived from the first volunteer was an order of magnitude greater than the following
nineteen subjects, this despite the most conservative set of experimental conditions. This
wide variation in results is similar to other investigators experience in similar published
dermal absorption study settings.
As compared to malathion and malaoxon, toluene and chloroform are smaller in
molecular weight but with similar oil-water partition coefficients. Thus, according to
Bogen’s equation, toluene and chloroform should have considerably larger permeability
constants (Kp). However, the experimentally derived Kpmalathion= .0005 L/cm2/hr
obtained in this study is in fact similar to those previously obtained by other investigators
for Kptoluene=.0008 L/cm2/hr and Kpcholoroform= 0.0001 L/cm2/hr.
It is interesting to note that many factors in the swimming pool exposure model may
enhance the typical Kpmalathion,. For example, water, ambient, and skin temperatures may
well be greater in swim exercise. These increased temperatures enhance skin absorption.
Also, during swimming or bathing, greater hydration of skin surfaces takes place, again
promoting Kp. For lipid-soluble malathion, lowered viscosity of tissue lipids at higher
temperatures reduces activation energies needed for diffusion. In addition, sunburned or

62

wounded skin, as well as hair follicles and sweat glands, accelerate dermal absorption.
Finally, skin sites in children appear to be more permeable than skin sites in adults. Thus,
the experimental Kpmalathion derived from this study is likely a conservative value.
Utilizing the experimentally-derived Kpmalathion, the Hazard Index (HI) for adult and child
swimmers immersed for three hours in a malathion only contaminated pool ranged from
0 – 0.08. These data indicate that exposure to dilute aqueous malathion solutions
following usual aerial bait applications is not appreciably absorbed, and therefore, not a
public health hazard.
Importantly, a potential problem arises in the analysis from the statement ‘usual aerial
bait application’. An atypical problem scenario exists with aerial bait application in that
malathion is easily oxidized to the more potent malaoxon by chlorine within swimming
pools. This fact is evidenced by the fact that both California and Florida environmental
agencies and public health authorities found considerable malaoxon contamination of
public and private swimming pools in the days and weeks following aerial bait
application.
In vivo, parent malathion must be metabolically activated to malaoxon by oxidative
desulfuration to be an effective AChE inhibitor. This activation step is carried out by both
mammals and insects, but insects are relatively deficient in the carboxylesterases used by
mammals for detoxification. Thus, insects have higher toxicity to malathion generally
speaking. However, humans may have similar malathion toxicity profiles to insects if and
when liver carboxylesterase is inactivated. One compound well known to inactivate liver
carboxylesterase is malaoxon, which may do so if absorbed ex vivo from contaminated
swimming pools.
Since malaoxon is 68 times as toxic as malathion, human volunteer exposure to same,
with or without concurrent exposure to malathion, is generally deemed too dangerous for
human experimentation. Therefore, in order to analyze the potential toxicity of external
malaoxon contamination and exposure in the swimming pool model, it is necessary to
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estimate Kpmalaoxon. Fortunately, Bogen’s empirical formula for Kp values based upon
molecular weight and oil-water partition coefficient values can be utilized for same. In
this case, owing to the more polar qualities of malaoxon, Kpmalaoxon is estimated to be
one-half that of Kpmalathion.
The Hazard Index for swimmers immersed for three hours in a malathion plus malaoxon
contaminated pool was modeled utilizing the experimentally-derived Kpmalathion, and
Bogen’s technique to estimate Kpmalaoxon. This methodology yielded an average HI=0.21
for adult swimmers, with HI for child swimmers similarly averaging 0.29. Although
HI>1 (albeit slightly) at the UCL (two standard deviations) for the volunteer group
modeled in this malathion plus malaoxon exposure model, even these data indicate there
is no appreciable public health hazard.
In order to lessen uncertainty in the hazard index estimate for malathion plus malaoxon
exposure scenarios, further animal or human experimental dermal absorption data is
clearly indicated in order to determine Kpmalaoxon with more certainty. Since human
volunteers should not be utilized in experiments with this toxic compound, the next best
available alternative is hairless guinea pig skin. Bogen and others have determined that
the hairless guinea pig is a superb model for human dermal skin absorption, and a similar
disappearance method to that used in this protocol can be effectively used with this
guinea pig animal model. Thus, potentially synergistic contaminant toxicity profiles for
malathion plus malaoxon may be more precisely determined in the future (Bogen, 1992).
Additional routes of entry for malathion and its co-products to enter into a swimmers
body exist but have not yet been integrated within the theoretical model described in this
paper. EPA estimates that children who swim for 3 hours daily take in and squirt out of
their mouths 16 liters of pool water and ingest 1% of that amount. The residence time for
each 5 ml aliquot in the mouth will be about 1.75 seconds, and during this time period
about 1% of the malathion will be absorbed through the buccal and sublingual mucous
membranes. Additional absorption is possible again through the orbital, nasal, aural, and
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inhalation routes. These unaccounted for routes of ingestion, absorption, and inhalation in
the swimmer may increase total dosage exposure scenarios by up to 50%.
The most neglected aspect of pesticide toxicity investigation in mammals remains
zeroing in on the toxicity of breakdown products of the parent compound. In fact, the
toxicity profile of mixtures of parent and breakdown products may be synergistic in
nature. Measurements of skin absorption rely on data obtained from single compound
solutions. This technique may underestimate absorption in the more common scenario of
multiple exposures to solvent mixtures in the contaminated water. Studies show that
combinations of compounds have greater effect on the stratum corneum, and are
absorbed more readily. In addition, potent impurities such as malaoxon, isomalathion,
O,O,S-trimethyl phosphorothioate and diethyl fumarate may contribute synergistically to
the toxicity of technical malathion formulations both before and after usual aerial bait
application (Aldridge, 1979). For example, a difference of a day or two in bait application
on two adjacent areas could result in a condition in which a considerable quantity of the
breakdown product along with a substantial quantity of the parent compound could be
washed by rainfall into the common water source. In a single body of water, daily pH
fluctuations could conceivably be responsible for producing synergistic conditions as
well. The rapid production of diethyl fumarate could occur during the period when pH is
high, its rate of production being reduced after the active photosynthetic period, leaving
enough malathion to produce synergistic toxic effects (Bender, 1969).
These data suggest that the toxic exposure profile of the population swimming in the
spray area may be significantly different than the profile measured in the original bait
spray tank. As a minimal standard, prior to spray application, analysis should be
considered for potent and toxic contaminants (e.g. isomalathion, malaoxon, diethyl
fumarate) within the technical malathion formula. In addition, after spray application,
similar analysis should be considered for swimming pools within these same designated
spray areas. In fact, partially as a result of this type of analysis, California ultimately cut
its target aerial spray malathion concentrations from 2.4 to 1.2 ounces per acre, then
subsequently abandoned malathion completely in favor of biological controls in 1994.
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Chapter Ten
Conclusion
Malathion skin absorption measured among 58% of the human volunteers by the
disappearance method allowed for experimental determination of Kpmalathion=.0005
L/cm2/hr. The dosage in human volunteers from this controlled exposure to a
contaminated aquarium solution was several orders of magnitude less than the minimal
dose necessary to cause measurable change in red blood cell acetylcholinesterase (RBCAChE). Following experimental determination of Kpmalathion, a mathematical model was
evaluated for swimmers using dilute aqueous malathion contamination concentrations
typically detected after bait application. Extrapolation of Kpmalathion into swimming pool
exposures (both adults and children, with and without malaoxon) resulted in dosages an
order of magnitude below that needed to cause a detectable change in RBC-AChE. These
data indicate that exposure to aqueous malathion following usual aerial bait applications
is not appreciably absorbed, and therefore, not a public health hazard.
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